(NASDAQ: IVF) Invo Fertility's forecast annual revenue growth rate of 48.48% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.99%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.71%.
Invo Fertility's revenue in 2026 is $6,943,899.On average, 2 Wall Street analysts forecast IVF's revenue for 2026 to be $3,980,398, with the lowest IVF revenue forecast at $3,862,382, and the highest IVF revenue forecast at $4,138,132. On average, 2 Wall Street analysts forecast IVF's revenue for 2027 to be $6,288,901, with the lowest IVF revenue forecast at $6,102,042, and the highest IVF revenue forecast at $6,537,794.
In 2028, IVF is forecast to generate $3,549,564 in revenue, with the lowest revenue forecast at $3,444,030 and the highest revenue forecast at $3,690,275.